ZERBAXA

Peak

ceftolozane and tazobactam

NDAINTRAVENOUSPOWDERPriority Review
Approved
Dec 2014
Lifecycle
Peak
Competitive Pressure
0/100

Loss of Exclusivity

LOE Date
Aug 14, 2035
114 months away
Patent Expiry
Aug 14, 2035

Patent Records (5)

Patent #ExpiryTypeUse Code
7129232
May 15, 2028
SubstanceProduct
U-3360
10028963
Sep 7, 2032
U-2565
9724353
Sep 7, 2032
U-2566
8968753
Mar 14, 2034
U-3360
9872906
Mar 14, 2034
Product
—
External Resources
DailyMed
Full prescribing information
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers